Calu - calumenin Gene

Also Known as Rcn; Cbp50

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 64366

Summary

Enables calcium ion binding activity; enzyme binding activity; and enzyme inhibitor activity. Involved in peripheral nervous system axon regeneration and response to organic cyclic compound. Located in endoplasmic reticulum lumen. Orthologous to human CALU (calumenin). [provided by Alliance of Genome Resources, Apr 2022]

Calu Products (2)

mRNA Protein Name
NM_001033898.1 NP_001029070.1 calumenin isoform b precursor
NM_022535.2 NP_071980.2 calumenin isoform a precursor

Gene Ontology

  • Molecular Function
  • Biological Process
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables calcium ion binding IDA
IDA: Inferred from direct assay
8416973 RGD
enables enzyme binding IDA
IDA: Inferred from direct assay
15075329 RGD
enables enzyme inhibitor activity IDA
IDA: Inferred from direct assay
15075329 RGD
Biological Process GO Annotation Evidence References Source
involved in peripheral nervous system axon regeneration IEP
IEP: Inferred from expression pattern
15509515 RGD
involved in response to organic cyclic compound IEP
IEP: Inferred from expression pattern
17994578 RGD
Cellular Component GO Annotation Evidence References Source
located in endoplasmic reticulum lumen IDA
IDA: Inferred from direct assay
8416973 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

calumenin

  • CBP-50

  • crocalbin

  • reticulocalbin

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P991233 BAT1006 Inhibitor / Phase 2

Pre-clinical Phase

Bioactive Molecules (24)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-168664 CPD-39 Degrader 98.06% Unkown
HY-168660 CPD-10 98.59% Unkown
HY-137246 CD73-IN-3 Inhibitor 99.89% Unkown
HY-144269 SHR902275 Inhibitor 99.80% Unkown
HY-119992 CEP-6800 Inhibitor / Unkown
HY-149304 SARS-CoV-2-IN-40 Inhibitor / Unkown
HY-155014 SARS-CoV-2-IN-44 Inhibitor / Unkown
HY-155015 SARS-CoV-2-IN-45 Inhibitor / Unkown
HY-155016 SARS-CoV-2-IN-46 Inhibitor 99.77% Unkown
HY-156325 SARS-CoV-2-IN-62 Inhibitor / Unkown
HY-156337 SARS-CoV-2-IN-63 Inhibitor / Unkown
HY-156441 SARS-CoV-2-IN-65 Inhibitor / Unkown
HY-162313 NIP-22c Inhibitor / Unkown
HY-162492 Influenza A virus-IN-14 Inhibitor / Unkown
HY-170850 MKLP2-IN-1 Inhibitor / Unkown
HY-RS01849 CALU Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-162719 RH12 Inhibitor / Unkown
HY-163206 SARS-CoV-2-IN-77 Inhibitor / Unkown
HY-168917 9-Aminominocycline Inhibitor / Unkown
HY-173459 N-0920 Inhibitor / Unkown
HY-176280 SARS-CoV-2-IN-115 Inhibitor / Unkown
HY-N1107 Uzarigenin / Unkown
HY-RS19578 Calu Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26075 Calu Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Calu NCBI NCBI:813